Further studies demonstrated that Tim-AIII has therapeutic effect on NSCLC by binding to its target HSP90, which promotes ubiquitination and degradation of GPX4 ultimately induces NSCLC cells ferroptosis. This evidence concerns the gene GPX4 and non-small cell lung carcinoma.